These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15755764)

  • 1. Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?
    Pitt B
    N Engl J Med; 2005 Apr; 352(14):1483-4. PubMed ID: 15755764
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive lipid lowering with atorvastatin in coronary disease.
    Southern W
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003831
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive lipid lowering with atorvastatin in coronary disease.
    Auer J; Lamm G; Eber B
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16000362
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Gotto AM
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
    [No Abstract]   [Full Text] [Related]  

  • 7. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
    Langer A
    N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16251546
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Miller M
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensive statin therapy--a sea change in cardiovascular prevention.
    Topol EJ
    N Engl J Med; 2004 Apr; 350(15):1562-4. PubMed ID: 15007111
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive lipid lowering with atorvastatin in coronary disease.
    Cannon CP; Murphy SA; Braunwald E
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003832
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins in acute coronary syndromes: the sooner, the better?
    Schwartz GG
    Am Heart J; 2005 Mar; 149(3):377-80. PubMed ID: 15864223
    [No Abstract]   [Full Text] [Related]  

  • 13. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
    Barter P; Gotto AM; LaRosa JC; Maroni J; Szarek M; Grundy SM; Kastelein JJ; Bittner V; Fruchart JC;
    N Engl J Med; 2007 Sep; 357(13):1301-10. PubMed ID: 17898099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
    Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
    J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Auer J; Weber T; Eber B
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
    Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 19. High-intensity statin treatment for coronary heart disease.
    Sacks FM
    JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
    [No Abstract]   [Full Text] [Related]  

  • 20. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
    Einecke D
    MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.